Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Aminopyridine analogs selectively target metastatic pancreatic cancer
HTML
Details
Locations
Year:
2022
Type:
article
Source:
Oncogene
DOI:
10.1038/s41388-022-02183-3
Authors:
Rana V. Smalling,
Matthew E. Bechard,
Jeff Duryea,
Philip J. Kingsley,
Evan R. Roberts,
Lawrence J. Marnett,
Daniel Bilbao,
Shaun R. Stauffer,
Oliver G. McDonald
show all 9
Institutions:
Vanderbilt University,
Vanderbilt University Medical Center,
University of Miami,
Sylvester Comprehensive Cancer Center,
Cleveland Clinic
Language:
English
Topic:
Cancer, Hypoxia, and Metabolism
Subfield:
Cancer Research
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
SDG:
Good health and well-being
Open Access status:
green
Funders:
U.S. Department of Health and Human Services,
National Institutes of Health,
National Cancer Institute,
National Institute of Diabetes and Digestive and Kidney Diseases
Awards:
G2809205082,
G5347881727,
High resolution Thermo Scientific Q-Exactive Orbitrap mass spectrometer for metabolomics,
The Evolution of PGD Addiction in Human Pancreatic Cancer,
Molecular and Cellular Basis for Digestive Diseases
OpenAlex ID:
W4205463550
FWCI:
0.335
Cites:
41
Cited by:
4
Related to:
10